Public Art Abu Dhabi Launches with the Unveiling of WAVE Media Art Installation
Public Art Abu Dhabi Launches with the Unveiling of WAVE Media Art Installation
March 21, 2023 06:57 ET | Public Art Abu Dhabi
The Department of Culture and Tourism – Abu Dhabi’s new initiative is part of its ongoing commitment to commissioning public art for the emirate Three major long-term elements include Public Art Abu...
Wave App Counting Retail Apparel Inventory
SimplyRFID Unveils RFID Inventory for Shopify at the NRF Big Show
January 13, 2023 12:00 ET | SimplyRFiD
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- SimplyRFID's Wave 3.3.9 releases on January 20, 2023 and can be previewed at the NRF Big Show this week (Jan. 15-17) at booth #4246 in the Javits Center,...
Wave Logo with Swoosh_R.jpg
Wave Life Sciences to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference 2022
February 09, 2022 08:30 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
November 10, 2021 07:30 ET | Wave Life Sciences USA, Inc.
Strengthened balance sheet with approximately $52 million; focusing additional investment in RNA editing programs led by hepatic editing Optimized AIMers for AATD program demonstrate potent, highly...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare Conference
November 08, 2021 16:05 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
September 29, 2021 08:30 ET | Wave Life Sciences USA, Inc.
Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping First systemically administered therapeutic candidate with PN backbone chemistry modifications to be assessed in the clinic ...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
September 28, 2021 16:05 ET | Wave Life Sciences USA, Inc.
Durable ADAR editing in vivo in preclinical models, including in CNS tissues with editing out to at least four months Chemistry optimization yields a four-fold increase over PBS control in AAT...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
September 22, 2021 16:05 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
D2L logo.png
D2L INTRODUCES D2L WAVE—THE FUTURE OF UPSKILLING AND RESKILLING
July 07, 2021 09:52 ET | D2L
Kitchener, Waterloo, July 07, 2021 (GLOBE NEWSWIRE) -- Global learning technology leader D2L today announced the launch of D2L Wave, a bold new approach to professional development that makes it...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
May 28, 2021 08:30 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 28, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...